NAFLD (NONALCOHOLIC FATTY LIVER DISEASE)
Clinical trials for NAFLD (NONALCOHOLIC FATTY LIVER DISEASE) explained in plain language.
Never miss a new study
Get alerted when new NAFLD (NONALCOHOLIC FATTY LIVER DISEASE) trials appear
Sign up with your email to follow new studies for NAFLD (NONALCOHOLIC FATTY LIVER DISEASE), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Diet showdown: mediterranean vs DASH for fatty liver
Disease control CompletedThis study tested whether Mediterranean or DASH diets improve liver function in people with nonalcoholic fatty liver disease (NAFLD). 75 adults with mild to moderate liver enzyme elevations were split into three groups: one following general dietary guidelines, one on a Mediterra…
Matched conditions: NAFLD (NONALCOHOLIC FATTY LIVER DISEASE)
Phase: NA • Sponsor: University of Lahore • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Which diabetes drug fights fatty liver better? new study pits dapagliflozin against empagliflozin
Disease control CompletedThis completed phase 4 trial compared two common diabetes drugs, dapagliflozin and empagliflozin, added to metformin in 108 adults with type 2 diabetes and nonalcoholic fatty liver disease (NAFLD). Participants took one of the two drugs daily for six months. Researchers used live…
Matched conditions: NAFLD (NONALCOHOLIC FATTY LIVER DISEASE)
Phase: PHASE4 • Sponsor: Beni-Suef University • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC